Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has proposed a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025, with the Hong Kong dollar equivalent, exchange rate, and applicable withholding tax details to be announced. The ex-dividend date is set for 27 May 2026, with the book closure period from 29 May to 2 June, a record date of 2 June, and payment scheduled for 18 June 2026, indicating continued capital returns to shareholders and a defined timetable for investors seeking entitlement to the payout.
The most recent analyst rating on (HK:2190) stock is a Hold with a HK$28.00 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a Hong Kong-listed medical technology company focused on developing and commercializing medical devices. The group operates in the healthcare sector, with its shares traded under stock code 02190, and is overseen by a board comprising executive, non-executive, and independent non-executive directors.
Average Trading Volume: 700,433
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.31B
Find detailed analytics on 2190 stock on TipRanks’ Stock Analysis page.